|
GSK256066
Description of:GSK256066
GSK256066 is an exceptionally high affinity and selective inhibitor of PDE4 that inhibits PDE4 isoforms A-D with equ...
更多>>
|
|
|
Cilomilast(SB-207499)
Description of:Cilomilast(SB-207499)
Cilomilast (SB-207499) inhibits HPDE4 and LPDE4 catalytic activity with equal potency (Ki ≈100 nM). ...
更多>>
|
|
|
TH-302
Description of:TH-302
TH-302 is a selectively targeting hypoxic regions of solid tumors hypoxia-activated prodrug.
Theoretical analysis:T...
更多>>
|
|
|
TAK-700 (Orteronel)
Description of:TAK-700 (Orteronel)
orteronel(TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prost...
更多>>
|
|
|
Avasimibe(CI-1011)
Description of:Avasimibe(CI-1011)
Avasimibe (CI-1011) is an orally bioavailable Acyl-CoA:Cholesterol O-Acyltransferase (ACAT) inhibitor.
T...
更多>>
|
|
|
Apixaban
Description of:Apixaban
Apixaban is a compound being investigated as an anticoagulant. Apixaban has similar affinity for human and rabbit facto...
更多>>
|
|
|
Rivaroxaban(Xarelto)
Description of:Rivaroxaban(Xarelto)
Rivaroxaban significantly reduced the primary efficacy end point, as compared with placebo, with respective...
更多>>
|
|